Phenergan and Proamatine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phenergan (promethazine hydrochloride) and Proamatine (midodrine hydrochloride). Common drug interactions include ocular icterus among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Phenergan and Proamatine. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.

What is Proamatine?

Proamatine has active ingredients of midodrine hydrochloride. It is often used in hypotension. eHealthMe is studying from 968 Proamatine users. Check the latest studies of Proamatine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

28 people who take Phenergan and Proamatine together, and have interactions are studied.

Phenergan and Proamatine drug interactions.

What are the common drug interactions of Phenergan and Proamatine, by gender? *:

female:

  1. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  2. Oedema peripheral (superficial swelling)
  3. Pain of skin
  4. Pneumonia
  5. Postmenopausal haemorrhage (post-menopausal bleeding)
  6. Skin hyperpigmentation (disorders affect the colour of your skin)
  7. Skin hypertrophy (skin cells enlarges)
  8. Skin induration (an abnormally hard spot or area on the skin)
  9. Skin plaque (red, scaly patches to appear on the skin)
  10. Skin tightness

male:

  1. Cardiac failure congestive
  2. Pneumonia
  3. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  4. Hepatic failure (liver failure)
  5. Liver disorder (liver diseases)
  6. Pulmonary hypertension (increase in blood pressure in the lung artery)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Septic shock (shock due to blood infection)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Phenergan and Proamatine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Rectal haemorrhage (bleeding from anus)
  2. Suicidal ideation
  3. Adrenal disorder
  4. Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
  5. Diarrhoea
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  9. Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
  10. Blindness

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Asthenia (weakness)
  3. Deformity (disfigurement)
  4. Erythema (redness of the skin)
  5. Exfoliative rash (scaly red generalized skin rash)
  6. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  7. Gait disturbance
  8. General physical health deterioration (weak health status)
  9. Joint contracture (a permanent shortening of a muscle or joint)
  10. Joint range of motion decreased (disease of joint movement)

50-59:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Arrhythmia (irregular heartbeat)
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  4. Cardiac failure congestive
  5. Cardiac output decreased
  6. Cardiogenic shock (inadequate circulation of blood)
  7. Cerebellar ischaemia (lack of blood supply to cerebeller)
  8. Encephalopathy (functioning of the brain is affected by some agent or condition)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Haematoma (collection of blood outside the blood vessels)

60+:

  1. Diplegia (paralysis of corresponding parts on both sides of the body)
  2. Haemorrhage (bleeding)
  3. Oesophageal candidiasis (fungal infection of oesophagus)
  4. Pharyngeal disorder
  5. Pneumonia
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  8. Blood erythropoietin increased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Decreased appetite

What are the existing conditions these people have? *

  1. Pain: 4 people, 14.29%
  2. Stress And Anxiety: 3 people, 10.71%
  3. Nausea And Vomiting: 3 people, 10.71%
  4. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 7.14%
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 7.14%
  6. Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 2 people, 7.14%
  7. Pain In Extremity: 2 people, 7.14%
  8. Neuropathy Peripheral (surface nerve damage): 2 people, 7.14%
  9. Migraine (headache): 2 people, 7.14%
  10. High Blood Pressure: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Phenergan and Proamatine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phenergan and Proamatine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proamatine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenergan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proamatine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride and midodrine hydrochloride (the active ingredients of Phenergan and Proamatine, respectively), and Phenergan and Proamatine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: